PATENT CLAIM ANALYSIS

Application Number: 16014295
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "210210"]

Abstract:
Provided are benzenesulfonamide derivatives or pharmaceutically acceptable salts thereof. Also provided is a method for treating cancer by using a pharmaceutical composition including the benzenesulfonamide derivatives or pharmaceutically acceptable salts thereof and pharmaceutically acceptable carriers.

Claim (Index 13):
The method of  claim 4 , wherein the cancer is at least one selected from the group consisting of liver cancer, lung cancer, breast cancer, head and neck cancer, colon cancer, renal cancer, skin cancer, cervical cancer, prostate cancer, pancreatic cancer and gastric cancer.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.42308
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15387221', '15036384', '14361548', '14453502', '15566872']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7409882548354071
- 35 USC 102 Novelty (BERT): 0.509842439580369
- Combined Prediction Score: 0.7178736733099033
- Mean Citation Score: 169.93924199999995
- Max Citation Score: 180.09967
- Similarity Product: 102.83046709700228

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test